Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-066369
Filing Date
2025-03-28
Accepted
2025-03-28 09:08:31
Documents
5
Effectiveness Date
2025-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 d945264ds8.htm S-8 39441
2 EX-5.1 d945264dex51.htm EX-5.1 9668
3 EX-23.2 d945264dex232.htm EX-23.2 1804
4 EX-FILING FEES d945264dexfilingfees.htm EX-FILING FEES 18439
5 GRAPHIC g945264g0328132236877.jpg GRAPHIC 2091
  Complete submission text file 0001193125-25-066369.txt   73388
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286208 | Film No.: 25781776
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)